Intuitive Surgical, Inc. $ISRG Stake Increased by Impax Asset Management Group plc

Impax Asset Management Group plc boosted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.3% during the 2nd quarter, Holdings Channel reports. The institutional investor owned 133,228 shares of the medical equipment provider’s stock after buying an additional 5,515 shares during the period. Impax Asset Management Group plc’s holdings in Intuitive Surgical were worth $71,710,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of ISRG. Tobam increased its holdings in shares of Intuitive Surgical by 666.7% in the 2nd quarter. Tobam now owns 46 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 40 shares during the period. TD Capital Management LLC grew its position in Intuitive Surgical by 300.0% during the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock valued at $30,000 after purchasing an additional 45 shares in the last quarter. 1248 Management LLC acquired a new position in Intuitive Surgical in the 1st quarter valued at approximately $30,000. Princeton Global Asset Management LLC purchased a new stake in Intuitive Surgical in the 2nd quarter worth approximately $30,000. Finally, Bank of Jackson Hole Trust lifted its position in Intuitive Surgical by 70.5% in the 1st quarter. Bank of Jackson Hole Trust now owns 75 shares of the medical equipment provider’s stock worth $37,000 after buying an additional 31 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Stock Up 0.0%

NASDAQ:ISRG opened at $572.45 on Thursday. The company’s 50 day moving average is $478.64 and its 200-day moving average is $502.49. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $616.00. The firm has a market cap of $205.21 billion, a price-to-earnings ratio of 75.72, a P/E/G ratio of 4.94 and a beta of 1.62.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.99 by $0.41. The business had revenue of $2.51 billion for the quarter, compared to analyst estimates of $2.41 billion. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. Intuitive Surgical’s revenue was up 22.9% compared to the same quarter last year. During the same period last year, the business posted $1.84 EPS. Research analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, EVP Myriam Curet sold 7,562 shares of the stock in a transaction that occurred on Tuesday, October 28th. The stock was sold at an average price of $548.43, for a total value of $4,147,227.66. Following the completion of the sale, the executive vice president directly owned 353 shares of the company’s stock, valued at approximately $193,595.79. This represents a 95.54% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO David J. Rosa sold 24,500 shares of the firm’s stock in a transaction on Friday, October 24th. The stock was sold at an average price of $547.55, for a total transaction of $13,414,975.00. Following the completion of the sale, the chief executive officer owned 234,256 shares in the company, valued at approximately $128,266,872.80. The trade was a 9.47% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 101,683 shares of company stock valued at $53,517,192 in the last ninety days. Company insiders own 0.70% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on the stock. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Intuitive Surgical in a research note on Friday, October 31st. Raymond James Financial set a $603.00 target price on Intuitive Surgical and gave the stock an “outperform” rating in a research report on Wednesday, October 22nd. Mizuho set a $575.00 price target on Intuitive Surgical in a report on Wednesday, October 22nd. Wells Fargo & Company boosted their price target on Intuitive Surgical from $599.00 to $600.00 and gave the company an “overweight” rating in a research note on Wednesday, October 22nd. Finally, Leerink Partners raised their price objective on shares of Intuitive Surgical from $593.00 to $600.00 and gave the company an “outperform” rating in a research report on Wednesday, October 22nd. Two investment analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $608.92.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.